What this CTMS screenshot shows
This interface displays a Study Risk Assessment record within Veeva Vault CTMS, specifically for the synthetic demonstration study AVEG 027. The record is in an Approved lifecycle state, showing an overall risk score of 36.47 percent. The page layout features a left-hand navigation panel for jumping to specific sections, such as Study Risk Categories, Study Risks, and Study Risk Mitigations. The main content area presents metadata at the top, including the associated study, version number, and risk assessment document. Below the metadata, the interface displays collapsible sections for detailed risk management. The Study Risks section is expanded, showing a structured table of risk discussion points, their evaluated impact, probability, detectability, calculated risk scores, visual risk symbols, and rationales. This view provides clinical operations teams with a centralized, structured overview of evaluated study risks.
Visible interface elements
- Left navigation panel listing Study Risk Categories, Study Risks, and Study Risk Mitigations with associated record counts.
- Record metadata header displaying the study name AVEG 027, version number 2, and an overall risk score of 36.47 percent.
- Approved lifecycle state badge next to the Study Risk Assessment title.
- Expanded Study Risks table containing columns for Discussion Points, Impact, Probability, Detectability, Risk Score, Risk Symbol, and Rationale.
- Table controls including a Create button, a search input field, and a Show in Tab button.
- Visual risk symbols within the table, including red circles, orange triangles, and green checkmarks.
- Pagination indicator showing 1-20 of 63 records across 4 pages.
Interface details
The interface is structured with a standard Veeva Vault header containing global search, document navigation tabs, and user profile controls. Below the header, the main workspace displays the record title, "Study Risk Assessment: AVEG 027 - Study Risk Assessment," alongside an Approved status badge. The left-hand sidebar lists key record components with count indicators, such as thirteen Study Risk Categories, sixty-three Study Risks, and two hundred and eighteen Study Risk Mitigations. In the main panel, the Study Risks section is expanded to show a tabular grid. This grid includes columns for Discussion Points, Impact, Probability, Detectability, Risk Score, Risk Symbol, and Rationale. Users can interact with this table using the search bar, a Create button, and a Show in Tab option. Pagination controls at the top right of the table indicate that twenty of the sixty-three risk records are currently visible. The table rows display qualitative assessments like High, Medium, and Low, alongside numerical risk scores and color-coded risk symbols, such as red circles and orange triangles, to visually categorize risk severity.
Workflow context
The Study Risk Assessment workflow is a key component of clinical trial management, enabling study teams to identify, evaluate, and mitigate potential operational risks. In this specific view, the assessment for study AVEG 027 has progressed through its lifecycle to the Approved state, as indicated by the metadata and the approved date of April 5, 2021. The structured table of Study Risks allows clinical operations personnel to systematically review specific discussion points, such as eligibility criteria complexity, subject randomization requirements, and blinding administration. By assigning qualitative values for impact, probability, and detectability, the system calculates a numerical risk score for each item. This structured approach helps teams prioritize high-risk areas, document rationales, and link risks to corresponding mitigations, ensuring robust oversight and compliance throughout the trial lifecycle.
Source, version, and interpretation limits
The screenshot is a frame from the official Veeva YouTube demo titled CTMS Oversight Deep Dive Demo, published in March 2022. Because this image represents a demonstration environment, the visible data, including study names, dates, risk scores, and specific discussion points, are synthetic and intended for illustrative purposes only. The browser chrome and demo tenant URL are visible at the top of the frame. Actual user interfaces, available fields, and specific workflows may vary depending on the customer's specific Vault configuration, release version, and active user permissions.
Authoritative references
Use these primary sources to confirm current product positioning, terminology, and release-specific behavior.
- CTMS Oversight Deep Dive Demo(Official Veeva YouTube demo)
- Veeva CTMS product overview(Official Veeva product page)
- Veeva CTMS trial-management overview(Official Veeva resource)
